Literature DB >> 22484454

Clinicopathological features of human brainstem gliomas.

Hidehiro Oka1, Satoshi Utsuki, Yoshinori Tanizaki, Hiroyuki Hagiwara, Yoshiteru Miyajima, Kimitoshi Sato, Mari Kusumi, Chihiro Kijima, Kiyotaka Fujii.   

Abstract

We describe the clinicopathological features of 25 brainstem gliomas (BSGs). Twenty BSGs located in the pons and were all in children. Four BSGs located in the medulla oblongata were in 2 children and 2 adults. One (in a child) was located in the midbrain. Radiological findings on MR images were low-intensity on T1 weighted images and high-intensity on T2 weighted images. Mean survival when pontine glioma was treated by radiotherapy and/or use of temozolomide was 14 months, although 4 patients (3 cervicomedullary types and one focal type arising from midbrain) are alive. Follow up was from 5 months to 6 years. Histopathological features of 10 cases of the diffuse type were: 4 grade II astrocytomas, 4 grade III astrocytomas, and 2 glioblastomas. MIB-1 index was from 0.8 to 38 %. P53 was positive for 80 % of 15 tumors and there were no negative results. MGMT was positive in 60 % of 15 tumors and negative in 12.4 %. IDH1 was negative in 61.6 %. There was no positive result for IDH1 in this study. Thus, our histopathological results were indicative of high p53 immunoreactivity and no IDH1 immunoreactivity related to secondary malignant change.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484454     DOI: 10.1007/s10014-012-0099-8

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  10 in total

Review 1.  Zinc and zinc-containing biomolecules in childhood brain tumors.

Authors:  Jan Hrabeta; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Sona Krizkova; Vojtech Adam
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

2.  Measurements of the pons as a biomarker of progression for pediatric DIPG.

Authors:  Emilie A Steffen-Smith; Eva H Baker; David Venzon; Shaefali Shandilya; Robyn S Bent; Katherine E Warren
Journal:  J Neurooncol       Date:  2013-10-10       Impact factor: 4.130

3.  Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas.

Authors:  Leomar Y Ballester; Zengfeng Wang; Shaefali Shandilya; Markku Miettinen; Peter C Burger; Charles G Eberhart; Fausto J Rodriguez; Eric Raabe; Javad Nazarian; Katherine Warren; Martha M Quezado
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

4.  Clinicopathological features and treatment outcomes of brain stem gliomas in Saudi population.

Authors:  Yasser Bayoumi; Abdulrahman J Sabbagh; Reham Mohamed; Usama M ElShokhaiby; Ahmed Marzouk Maklad; Mutahir A Tunio; Ali Abdullah O Balbaid
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 5.  Progressive multifocal exophytic pontine glioblastoma: a case report with literature review.

Authors:  Fanfan Chen; Zongyang Li; Chengyin Weng; Peng Li; Lanbo Tu; Lei Chen; Wei Xie; Ling Li
Journal:  Chin J Cancer       Date:  2017-03-27

6.  Adult Diffuse Astrocytoma in the Medulla Oblongata: Molecular Biological Analyses Including H3F3A Mutation of Histone H3.3.

Authors:  Ken Uekawa; Hideo Nakamura; Naoki Shinojima; Tatsuya Takezaki; Shigetoshi Yano; Jun-Ichi Kuratsu
Journal:  NMC Case Rep J       Date:  2015-09-08

7.  IDH1 Mutation in Brain Stem Glioma: Case Report and Review of Literature.

Authors:  Seyed Amirhossein Javadi; Christian Hartmann; Gerhard Franz Walter; Roozbeh Banan; Amir Samii
Journal:  Asian J Neurosurg       Date:  2018 Apr-Jun

Review 8.  MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas.

Authors:  Hideaki Abe; Manabu Natsumeda; Yu Kanemaru; Jun Watanabe; Yoshihiro Tsukamoto; Masayasu Okada; Junichi Yoshimura; Makoto Oishi; Yukihiko Fujii
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-05-31       Impact factor: 1.742

9.  MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas.

Authors:  Hideaki Abe; Manabu Natsumeda; Masayasu Okada; Jun Watanabe; Yoshihiro Tsukamoto; Yu Kanemaru; Junichi Yoshimura; Makoto Oishi; Rintaro Hashizume; Akiyoshi Kakita; Yukihiko Fujii
Journal:  Front Oncol       Date:  2020-01-21       Impact factor: 6.244

10.  Pediatric Brainstem Gliomas: An Institutional Experience.

Authors:  Altaf Ali Laghari; Mirza Zain Baig; Ehsan Bari; Aneela Darbar; Naureen Mushtaq; Umm E Hani Abdullah; Daniyal Aziz Khan
Journal:  Asian J Neurosurg       Date:  2019-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.